Package Leaflet: Information for the User
Algifast 400 mg powder for oral suspension
Ibuprofen (lysine)
Read this leaflet carefully before you start taking this medicine because it contains important information for you.
Follow exactly the administration instructions for the medicine contained in this leaflet or those indicated by your doctor or pharmacist.
1. What Algifast is and what it is used for
2. What you need to know before taking Algifast
3. How to take Algifast
4. Possible side effects
5. Storage of Algifast
6. Contents of the pack and additional information
The ibuprofen, active ingredient of this medication, acts by reducing pain and fever.
This medication is used in adults for symptomatic relief of occasional mild or moderate pains,such as headaches, dental pain, menstrual cramps, muscle pains (contractures) or back pain (lumbago), aswell as in febrile states.
You should consult a doctor if it worsens or does not improve, if fever persists for more than 3 days or painfor more than 5 days.
Do not take Algifast if:
Warnings and precautions
Consult your doctor or pharmacist before starting to take this medication.
-Do not take more than 3 packets per day (1200 mg of ibuprofen per day), to avoid possible cardiovascular or heart problems.
Severe skin reactions associated with ibuprofen treatment have been reported.
Stop taking this medication and seek medical attention immediately if you experience any skin rash, membrane lesions, blisters, or other signs of allergy, as these may be the first signs of a severe skin reaction.
See section 4.
Infections
Ibuprofen may mask the signs of an infection, such as fever and pain. Therefore, this medication may delay the appropriate treatment of the infection, increasing the risk of complications. This has been observed in pneumonia caused by bacteria and skin infections related to chickenpox. If you take this medication while having an infection and the infection symptoms persist or worsen, consult a doctor without delay.
Interference with diagnostic tests:
If you are to undergo any diagnostic test (including blood, urine, etc.), inform your doctor that you are taking this medication, as it may alter the results.
Other medications and Algifast
Inform your doctor or pharmacist if you are using, have used recently, or may need to use any other medication, including those purchased without a prescription.
This medication may affect or be affected by other medications. For example:
If your doctor has prescribed an antiplatelet medication (to prevent blood clots) containing acetylsalicylic acid, and you are also taking this medication, you should separate the intake of both medications (see Advertencias and precauciones section).
Other medications may also affect or be affected by the treatment with this medication. Therefore, you should always consult your doctor or pharmacist before using Algifast with other medications.
Taking Algifast with food, drinks, and alcohol
Take this medication with meals or with milk.
The consumption of alcohol during treatment may increase the risk of gastrointestinal adverse reactions.
Pregnancy, breastfeeding, and fertility
If you are pregnant or breastfeeding, or think you may be pregnant or plan to become pregnant, consult your doctor or pharmacist before using this medication.
Ibuprofen should be avoided during the first and second trimesters of pregnancy. If it is considered essential, your doctor will prescribe the lowest effective dose and for the shortest possible duration. It should not be used in the last trimester of pregnancy.
Ibuprofen belongs to a group of medications that may reduce a woman's fertility (ability to become pregnant). This effect is reversible when the medication is stopped.
Driving and operating machinery
Although no effects are expected, use with caution if you experience drowsiness or dizziness.
Algifast contains cyclodextrin (betadex) (E-459), tartrazine (E-102), sucrose, and sodium.
Follow exactly the medication administration instructions contained in this leaflet or those indicated by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist.
The effective dose should be used for the shortest time necessary to relieve symptoms. If you have an infection, consult a doctor immediately if symptoms (such as fever and pain) persist or worsen (see section 2).
Adults and adolescents 12 years and older (and over 40 kg of weight)
It is recommended to take 1 tablet (400 mg of ibuprofen) every 6-8 hours, depending on the intensity of symptoms. Do not take more than 1200 mg of ibuprofen (3 tablets) in 24 hours.
Older patients
The dose should be established by the doctor, as it may be necessary to reduce the usual dose.Consult your doctor.
Patients with kidney, liver, or heart diseases:
They should consult a doctor before taking this medication.
The administration of this medication is subject to the appearance of pain or fever. As these disappear, the medication should be discontinued.
If symptoms worsen, if fever persists for more than 3 days or pain for more than 5 days, you should consult a doctor.
Administration form:
This medication is administered orally.
Empty the contents of a tablet into a half glass of water, shake, and take afterwards.
Take the medication with meals or with milk, especially if digestive discomfort is noted.
If you take more Algifast than you should
If you have taken more medication than you should, or if a child has accidentally ingested the medication, consult a doctor or pharmacist immediately or call the Toxicological Information Service (phone 91 562 04 20) indicating the medication and the amount ingested, or go to the nearest hospital to inform yourself about the risk and ask for advice on the measures to be taken.
The symptoms of overdose may include nausea, stomach pain, vomiting (which may contain blood), headache, ringing in the ears, confusion, and involuntary eye movement. At high doses, symptoms of drowsiness, chest pain, palpitations, loss of consciousness, seizures (mainly in children), weakness, and dizziness, blood in the urine, chills, and breathing difficulties have been reported.
Frequent (may affect up to 1 in 10 people): fatigue, headache, stomach and intestinal disorders (heartburn, diarrhea, nausea, vomiting), skin disorders (skin rashes, itching) and ear buzzing.
Less frequent (may affect up to 1 in 100 people): allergic reactions, asthma, rhinitis (inflammation of the nasal mucosa) and urticaria (skin rashes and intense itching), bleeding and gastrointestinal ulcers, sleep disturbances and mild anxiety, blurred vision, decreased visual acuity or changes in color perception and auditory disturbances.
Rare (may affect up to 1 in 1,000 people): edema (swelling due to fluid retention), blood disorders (leucopenia), stomach and intestinal perforation, liver disorders (including jaundice, i.e., yellow discoloration of the skin and eyes), kidney disorders consistent of: acute interstitial nephritis with hematuria (blood in urine), proteinuria (protein elimination through urine) and occasionally nephrotic syndrome (a set of symptoms that appear as a consequence of kidney damage); depression, vision disorders (obscurement of vision), neck stiffness and bronchospasm (sudden sensation of choking), dyspnea (difficulty breathing) and angioedema (inflammation of the deep layers of the skin, which is accompanied by swelling of the face, lips, tongue or throat, which may cause difficulty swallowing or breathing).
Very rare (may affect up to 1 in 10,000 people), the following may occur: aseptic meningitis (inflammation of the meninges not caused by bacteria), blood disorders (aplastic anemia and hemolytic anemia) and coagulation, hypertension and heart failure, severe skin disorders (erythema cutaneum), eyes and mucous membranes such as Stevens-Johnson syndrome (severe skin disease) and toxic epidermal necrolysis (skin and mucous membrane lesions that cause skin detachment) and erythema multiforme (inflammation of the skin).
Unknown frequency: a severe skin reaction known as DRESS syndrome may occur.
The symptoms of DRESS syndrome include:
a generalized red scaly rash, with bumps under the skin and localized blisters mainly on the skin folds, trunk and upper limbs, accompanied by fever at the beginning of treatment (generalized acute pustular exanthema). Stop taking Algifast if you experience these symptoms and seek medical attention immediately.
See also section 2. The skin becomes sensitive to light.
Reporting of adverse effects
If you experience any type of adverse effect, consult your doctor, pharmacist or nurse, even if it is a possible adverse effect that does not appear in this prospectus. You can also report them directly through the Spanish System for the Pharmacovigilance of Medicines for Human Use:https://www.notificaram.es. By reporting adverse effects, you can contribute to providing more information on the safety of this medicine.
This product does not require special storage conditions.
Once the package is opened, prepare the suspension immediately according to theinstructions for use.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date that appears on the package and the boxafter CAD. The expiration date is the last day of the month indicated.
Do not use this medication if you observe signs of deterioration.
Medicines should not be disposed of through drains or in the trash. Dispose of the containers andmedicines you no longer need at the SIGREcollection point at the pharmacy. If in doubt, ask yourpharmacist how to dispose of the containers and medicines you no longer need. By doing so, you will help protect the environment.
Composition of Algifast
Appearance of Algifastand contents of the packaging
Fine powder, white in color and with a lemon scent that is presented in sachets.
Each package contains 4 or 12 sachets.
Holder of the marketing authorization and responsible for manufacturingLaboratorio de Aplicaciones Farmacodinámicas, S.A. (FARDI)
Grassot, 16 - 08025- Barcelona (Spain)
Telephone: 932073751
Fax: 934570737
e-mail:[email protected]
Date of the last review of this leaflet:January 2021
The detailed and updated information on this medication is available on the website of theSpanish Agency of Medicines and Medical Devices (AEMPS)http://www.aemps.gob.es/
Have questions about this medication or your symptoms? Connect with a licensed doctor for guidance and personalized care.